Summary: A double standard exists whereby a treatment given outside a clinical trial is less stringently reviewed than a protocol treatment. We propose a remedy which would require the decision not to participate in an approved, available clinical trial to be subject to the same ethical requirements as trial entry.
|Number of pages||3|
|Journal||Annals of Oncology|
|Publication status||Published - 1 Feb 1992|
- Randomised clinical trial